Roland BELIARD

Roland Beliard has a diverse work experience in the biomanufacturing industry. Roland started their career at LFB as a Director of Projects in 2000 and then served as a Director of Monoclonal Antibody Programs until 2008. From 2008 to 2012, they worked as a Director of Preclinical Development. In 2012, they became the President of LFB and held this position until 2022. During their time at LFB, they also served as the Director of Bioproduction Europe and the Bioproduction Business Development Manager until 2022. In 2019, they briefly held the position of CEO before transitioning to their current role as the Director of Business Development at LFB Biomanufacturing starting from May 2022.

Roland Beliard pursued their doctoral studies in the field of life and health sciences, with a focus on immunology, from 1988 to 1991 at the Université de Franche-Comté. Roland obtained a doctorate degree from this university during the mentioned period.